We are taking on the biggest challenges for patients and our health care system.
As an industry, we are laser focused on developing innovative medicines and vaccines that transform lives and create a healthier America.
As we enter the second quarter of the 21st century, we are making four commitments to the American public:
We will change the trajectory of the most serious diseases, with an increased focus on prevention, to help protect patients and our health care system.
We will use the latest technology to improve our efficiency, as patients urgently require new treatments as soon as possible.
We will continue to do our part to support America in leading the world in biopharmaceutical innovation so that Americans can realize the benefits of that leadership.
We will work to improve the health care system so that it works better for patients.
I am hopeful. And, what that looks like to me is having a life that I used to have. When I think back on my life, my job in corporate America, the trajectory I was on with my family, I think an innovative cure would absolutely give me back the life that I had. So to me, that's absolutely critical for us to have access to the right medications, and for there to be research into rare diseases.”
Patty
Patient with Bell's Palsy
Protecting U.S. Leadership in Biopharmaceutical Innovation
Smart policies that foster innovation are the key to ensuring U.S. biopharmaceutical leadership. Recent actions, like drug price-setting policies in the Inflation Reduction Act, risk undermining the ecosystem that drives breakthrough treatments. These measures discourage risky, innovative research and threaten public-private collaborations that fuel advancements.
To maintain global leadership in biopharmaceutical innovation, the U.S. must protect its strong intellectual property system and uphold a predictable, science-based regulatory framework. Our industry is committed to advancing solutions that balance innovation and patient access, but sustaining leadership requires a supportive and predictable policy environment that encourages collaboration and risk-taking.
Our Work in Action
With the support of a unique ecosystem and policy environment that foster transformative advancements, this progress positions America as the global leader in biopharmaceutical innovation.
